rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2003-6-27
|
pubmed:abstractText |
T-cell depletion (TCD), primarily developed to prevent graft-vs-host disease (GVHD), might reduce early liver dysfunction after allogeneic hematopoietic stem cell transplantation. However, no comparative studies have been performed to investigate this. We analyzed the influence of selection for CD34(+) cells on the incidence and severity of hepatic veno-occlusive disease (VOD).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0301-472X
|
pubmed:author |
pubmed-author:ArbonaCristinaC,
pubmed-author:BrunetSalutS,
pubmed-author:CaballeroDoloresD,
pubmed-author:CampilhoFernandoF,
pubmed-author:Díez-MartínJosé LJL,
pubmed-author:EspigadoIldefonsoI,
pubmed-author:FerráChristelleC,
pubmed-author:MateosMaría VMV,
pubmed-author:MoraledaJosé MJM,
pubmed-author:MoscardóFedericoF,
pubmed-author:Pérez de OteyzaJaimeJ,
pubmed-author:PimentelPedroP,
pubmed-author:SanzGuillermo FGF,
pubmed-author:SanzMiguel AMA,
pubmed-author:SierraJordiJ,
pubmed-author:SolanoCarlosC,
pubmed-author:TalarnCarmenC,
pubmed-author:Urbano-IspizuaAlvaroA,
pubmed-author:VallejoCarlosC,
pubmed-author:ZuazuJavierJ
|
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
545-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12829031-Adolescent,
pubmed-meshheading:12829031-Adult,
pubmed-meshheading:12829031-Antigens, CD3,
pubmed-meshheading:12829031-Antigens, CD34,
pubmed-meshheading:12829031-Cell Count,
pubmed-meshheading:12829031-Female,
pubmed-meshheading:12829031-Hepatic Veno-Occlusive Disease,
pubmed-meshheading:12829031-Humans,
pubmed-meshheading:12829031-Incidence,
pubmed-meshheading:12829031-Male,
pubmed-meshheading:12829031-Middle Aged,
pubmed-meshheading:12829031-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:12829031-Siblings,
pubmed-meshheading:12829031-Transplantation, Homologous,
pubmed-meshheading:12829031-Transplantation, Isogeneic,
pubmed-meshheading:12829031-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
|
pubmed:affiliation |
Hematology Department, Hospital Universitario La Fe, Avda. Campanar 21, 46009 Valencia, Spain.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|